Floatz logo

Endostar

Refractory Tumor

Second Affiliated Hospital of Soochow Universityprotein_peptidePhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
89/ 100

Competitive context

10 Active assets in the Refractory Tumor cohort.

Asset / SponsorPhaseRating
Opb-111077
National University Hospital, Singapore
Phase 2CCC
Gm-Csf
Second Affiliated Hospital of Soochow University
Phase 2CCC
Thymalfasin
Second Affiliated Hospital of Soochow University
Phase 2CCC
rc48-adc
Shanghai Chest Hospital
Phase 1/2CC
IMMUNOGLOBULIN G1, ANTI-(HUMAN PROGRAMMED DEATH-LIGAND 1) (HUMAN MONOCLONAL STI-3031 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL STI-3031 .LAMBDA.-CHAIN, DIMER
Sorrento Therapeutics, Inc.
Phase 2CC

View all 13 →

Same molecule, other indications

Endostar is also rated in:

non-small cell lung carcinomaDormant
BB
Indicative ·
70 / 100
View asset →
colorectal neoplasmDormant
B
Indicative ·
63 / 100
View asset →
Leptomeningeal MetastasisDormant
B
Indicative ·
62 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →